제품 정보로 건너뛰기
1 의 1

ELK Biotechnology

SKU(재고 관리 코드):EPT074

Recombinant Mouse IDO (N-6His)

Recombinant Mouse IDO (N-6His)

가격·납기 및 기술자료를 확인해 드립니다.

제품 규격과 수량을 선택한 후 견적을 요청해 주세요. 대체품 검토와 SDS·COA·데이터시트 요청도 함께 접수할 수 있습니다.

이 제품 견적 요청

대표번호 070-8028-3500 · info@rndmate.com

MULTI-BRAND QUOTE
여러 제품을 함께 찾고 계신가요?
제조사가 달라도 괜찮습니다. 필요한 연구시약을 한 번에 견적받아보세요.
통합 견적 요청
Size
Description: Recombinant Mouse Indoleamine 2,3-dioxygenase is produced by our E.coli expression system and the target gene encoding Met1-Pro407 is expressed with a 6His tag at the N-terminus.
Accession: P28776
Molecular weight: 47.1 KDa
Apparent molecular weight: 40-50 KDa, reducing conditions
Other names: Indole 2;3-dioxygenase; Indoleamine 2;3-dioxygenase 1; IDO-1; IDO1; IDO; INDO
Storage condition: Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
Purity: Greater than 95% as determined by reducing SDS-PAGE.
Endotoxin: Less than 0.1 ng/µg (1 EU/µg) as determined by LAL test.
Storage: Store at ≤-70°C, stable for 6 months after receipt. Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.
Delivery condition: The product is shipped on dry ice/polar packs. Upon receipt, store it immediately at the temperature listed below.
Background: Indoleamine 2,3-dioxygenase (IDO) is a heme enzyme that initiates the oxidative degradation of the least abundant, essential amino acid, l-tryptophan, along the kynurenine pathway. This protein is normally expressed in the dendritic cells, macrophages, microglia, eosinophils, fibroblasts, endothelial cells, and most tumor cells. IDO activity is associated with immunosuppression and immune attenuation. Several studies showed that IDO can contribute to immune escape when expressed directly in tumor cells or when expressed in immunosuppressive antigen presenting cells such as tolerogenic dendritic cells or tumor associated macrophages. IDO also is a promising therapeutic target for the treatment of cancer, chronic viral infections, and other diseases characterized by pathological immune suppression.
전체 세부 정보 보기